‘Stand out’ firm ID Medical makes impression in Recruiter FAST 50 league

Award-winning multi-discipline healthcare recruiter ID Medical features in the Recruiter FAST 50 growth league for the fourth year running, achieving 3rd place – its highest ranking to date.

The resurgence of ID Medical in the highly anticipated FAST 50 report signals the company’s staying power and special combination of consistency and strong top line growth. In 2011 ID Medical was honoured to be placed 31st, and then rocketed to 9th in 2013. This year, ID Medical has improved its position even further, sitting proud in the top three.

With a compound sales growth of 62.44% over the last three years (only 0.42% from 2^nd position), ID Medical shows no sign of slowing down.

Mark Kingston, senior executive at mergers and acquisitions advisers Boxington Corporate Finance stated that ID Medical is one of only three firms in particular that stands out and has “done well to manage consistent growth over four consecutive years.”

The prominence of the Healthcare sector within the FAST 50 alludes to the increased use of temporary agency staff in the NHS, as well as the reduction in the number of suppliers.

Deenu Patel, ID Medical’s managing director commented, “There are many factors contributing to our enduring success. We’ve formed a quality business with quality people, whilst setting a strong growth strategy to expand into new market areas.

“We continue to see increased demand from our valued NHS clients to ensure they meet the satisfactory staffing levels for maintained patient care and safety – and we have to act fast. As a result of our capacity to supply superior medical professionals, we continue to be awarded onto NHS framework agreements.

“Our growth is also attributed to our ability to innovate and adapt to changing requirements. In particular, ID Medical’s newly implemented technology platform to manage staff bookings is proof that we are willing to acclimatise.

“We are overjoyed to be featured within the FAST 50 once again. This evidences not only our continued investment into our people and our methodologies, but our passion for the NHS and industry as an entirety.”

ENDS